Overview

This webinar mini-series will be held in three parts and moderated by Drs. Sahil A. Parikh, Azeem Latib, and Ziad Ali. Faculty members will present lectures and share cases to illustrate the utility of drug-coated balloons (DCBs) in various cardiac treatments.

DCBs are an example of advanced technology that can be used to treat CAD and PAD cases. DCBs may be especially helpful in CAD cases when there is concern about restenosis. In some cases, DCBs have shown efficacy in reducing the rates of restenosis compared to traditional angioplasty alone. Research has also shown that in some cases, DCBs can be used without the need for additional stent placement, reducing the risks associated with stent implantation and offering another patient treatment option for difficult-to-treat cases.

Learning Objectives

After attending this series, participants will be able to: 

• Discuss key data from coronary drug-coated balloon (DCB) clinical trials and their implications for clinical practice
• Select appropriate patients for coronary DCBs
• Plan for deployment of coronary DCBs, including step-by-step imaging guidance and lesion preparation
• Examine in-stent restenosis (ISR) cases, including single-layer, double-layer, and stent failure
• Explore other evidence-based applications of coronary DCBs

Target Audience

This course is suitable for: 

• interventional cardiologists
• invasive non-interventional cardiologists
• interventional cardiology fellows-in-training
• catheterization laboratory nurses and technicians

Agenda

• Coronary DCB Clinical Trials: Key Data and Their Implication for Practice—Dr. Parikh
• Getting It Right: Using IVUS, Lesion Preparation, and DCBs to Treat Stent Failure —Dr. Shlofmitz
• Case: Using DCBs to Treat In-Stent Restenosis—Dr. Kearney
• Panel Discussion—Drs. Batchelor and Croce
• DCB Billing and Reimbursement—Monica Wright (SCAI)

Accredited Continuing Education Information

Accreditation Statement

The Society for Cardiovascular Angiography and Interventions (SCAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.​

​Credit Designation

SCAI designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.​

​ABIM MOC

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 1.0 MOC point in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABIM MOC credit.

Successful Completion

Watch the content and complete the evaluation to obtain credit.

Acknowledgement of Commercial Support

This activity is supported by an unrestricted educational grant from Boston Scientific.            

Registration

Cost: Free